SKI-178: A Multitargeted Inhibitor of Sphingosine Kinase and Microtubule Dynamics Demonstrating Therapeutic Efficacy in Acute Myeloid Leukemia Models

Cancer Translational Medicine
doi 10.4103/ctm.ctm_7_17
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Medknow

Related search

The Apoptotic Mechanism of Action of the Sphingosine Kinase 1 Selective Inhibitor SKI-178 in Human Acute Myeloid Leukemia Cell Lines

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2015English

Frequent Loss of RAF Kinase Inhibitor Protein Expression in Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2012English

Tyrosine Kinase Inhibition in Acute Myeloid Leukemia

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2013English

A Review of Efficacy and Safety of Checkpoint Inhibitor for the Treatment of Acute Myeloid Leukemia

Frontiers in Pharmacology
Pharmacology
2019English

Comparison of Antitumor Effects of Multitargeted Tyrosine Kinase Inhibitors in Acute Myelogenous Leukemia

Molecular Cancer Therapeutics
Cancer ResearchOncology
2008English

Therapeutic Potential of GSK-J4, a Histone Demethylase KDM6B/JMJD3 Inhibitor, for Acute Myeloid Leukemia

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2018English

A Novel, Dual Pan-Pim/Flt3 Inhibitor SEL24 Exhibits Broad Therapeutic Potential in Acute Myeloid Leukemia

Oncotarget
Oncology
2018English

Acute Myeloid Leukemia With Mutated NPM1 Demonstrating Multilineage Dysplasia and Marked Thrombocytosis

British Journal of Haematology
Hematology
2017English

Pediatric Acute Myeloid Leukemia (AML): From Genes to Models Toward Targeted Therapeutic Intervention

Frontiers in Pediatrics
Child HealthPediatricsPerinatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy